IMGT Co.
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $23M
Investors
- 10
About IMGT Co.
, Ltd., Ltd. focuses on innovative technology solutions. The company has undergone strategic pivots to enhance its offerings and has successfully closed five deals to date. The founder, Marie-Paule Lefranc, has a history of entrepreneurial ventures, further strengthening the company's leadership., Ltd. delivers innovative technology solutions tailored to various industries, primarily through its advanced software platforms. These platforms improve operational efficiency and data management for medium to large enterprises across sectors such as healthcare, finance, and manufacturing.The company's revenue model includes subscription services and direct sales, where clients typically subscribe annually to access software updates and support. Customized solutions are offered based on specific client needs, ensuring a tailored approach to their operational challenges., Ltd.2 billion to advance the development of their ultrasound-sensitive drug delivery systems and therapeutic ultrasound devices, focusing on conducting clinical trials. The company aims to introduce new products that enhance healthcare solutions and is exploring expansion into additional markets, particularly in Europe and Asia, by 2023.
Who invested in IMGT Co.
10 investors across 3 rounds
See all investors in IMGT Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IMGT Co.
Who invested in IMGT Co.?
IMGT Co. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMGT Co. raised?
IMGT Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did IMGT Co. last raise money?
IMGT Co.'s most recent round on record is a Series C, in Dec 2021.
What does IMGT Co. do?
IMGT Co. is a biotechnology company.
Where is IMGT Co. headquartered?
IMGT Co. is headquartered in Seongnam, South Korea.
Which VCs invest in companies like IMGT Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at IMGT Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like IMGT Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.